High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy

Background: Colorectal cancer is the third most common cancer in both sex worldwide and it is also the fourth most common cause of cancer mortality. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage I...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Tian, Yu-Feng, Hsieh, Pei-Ling, Lin, Ching-Yih, Sun, Ding-Ping, Sheu, Ming-Jen, Yang, Ching-Chieh, Lin, Li-Ching, He, Hong-Lin, Solórzano, Julia, Li, Chien-Feng, Chang, I-Wei
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2017
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463434/
https://ncbi.nlm.nih.gov/pubmed/28607594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.18197
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料